Source study found
Story checked
Brain cancer risk linked with exposure to elevated concentrations of radon (opens in a new tab)
medicalxpress.com · 2026-10-12
Short answer
MixedMixed.
The claims we could check match the study, but some claims were not covered by the evidence reviewed.
- 3 supported
- 2 not covered
Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.
Share this check
The story
Brain cancer risk linked with exposure to elevated concentrations of radon
medicalxpress.com · 2026-10-12
The story’s checkable claims.
Read the original story (opens in a new tab)NewsLink checks it
Mixed
Every claim we could check holds up. Three of five claims match the study. This overall rating is based only on the claims we could check. Two claims the study doesn't address.
- 3 supported
- 2 not covered
The source study
Residential Radon Concentration and the Risk of Malignant Brain and Central Nervous System Cancer in US Postmenopausal Women
Source layer
The 2 papers the story cites
Source study separated from background citations.
The research anchor for the report.
- The study this story reportspresented as the new finding
Residential Radon Concentration and the Risk of Malignant Brain and Central Nervous System Cancer in US Postmenopausal Women
Neuroepidemiology · 2026
- Cited as backgroundpresented as earlier work
Residential Radon and Brain Tumour Incidence in a Danish Cohort
PLoS ONE · 2013
Evidence layer
Claim by claim
Each claim gets a verdict. Expand it to see the evidence directly below.
Reading mode
Scan verdicts. Open evidence only when needed.
Browse by verdict
5 claims in this storyShowing all 5 claimsChoose a verdict to focus the list.
Claim 1 of 5Not coveredThe study was led by Oregon State University scientists and was published in Neuroepidemiology.View evidenceHide evidence
Why this verdict
The supplied abstract-level paper profile does not include author affiliations, institutional leadership, or journal/publication metadata sufficient to verify that Oregon State University scientists led the study or that it was published in Neuroepidemiology.
Claim 2 of 5Not coveredThe American study featured a cohort more than double the size of the only previous examination of radon's potential link to central nervous system cancers, a 2013 study in Denmark that produced similar findings.View evidenceHide evidence
As statedmore than double the size
Why this verdict
The supplied profile does not provide enough background literature detail to verify that the Danish study was the only previous examination, that the U.S. cohort was more than double its size, or that the prior findings were similar.
Claim 3 of 5SupportedLong-term tracking of nearly 160,000 people from across the United States suggests that brain cancer risk rises as exposure to radon increases.View evidenceHide evidence
As statednearly 160,000 people
Why this verdict
The abstract-level profile supports a large prospective WHI cohort of 159,391 U.S. postmenopausal women followed for a mean 17.7 years, with higher residential radon estimates associated with increased malignant CNS cancer hazard. The story frames this as suggestive/associational, which matches the observational evidence, though 'people' is less precise than the paper population of postmenopausal women and 'brain cancer' is narrower wording than malignant brain/CNS cancer.
Study evidence
Cohort experience and outcome count: 159,391 postmenopausal women with mean 17.7 years follow-up; 451 incident malignant CNS cancers identified.
“We estimated the radon-related hazard of incident malignant CNS cancer in a large US cohort of postmenopausal women from the Women's Health Initiative.”
Claim 4 of 5SupportedFollowing the Women's Health Initiative cohort for about 18 years, the scientists identified 451 central nervous system cancer cases and estimated radon exposure from geological and environmental data sources.View evidenceHide evidence
As stated451 central nervous system cancer cases; about 18 years
Why this verdict
The profile reports the Women's Health Initiative cohort, 159,391 participants, mean 17.7 years of follow-up, 451 incident malignant CNS cancers, and residential radon estimates assigned from USGS/EPA zones and LBL/Li modeled estimates. 'About 18 years' and indirect exposure estimation from geological/environmental sources are consistent with the abstract.
Study evidence
Cohort experience and outcome count: 159,391 postmenopausal women with mean 17.7 years follow-up; 451 incident malignant CNS cancers identified.
“We estimated the radon-related hazard of incident malignant CNS cancer in a large US cohort of postmenopausal women from the Women's Health Initiative.”
Claim 5 of 5SupportedBozigar said, 'Absolute risks of malignant central nervous system cancers rose with higher radon concentration across all metrics,' and Mowrer said residential radon exposure may contribute meaningfully to the overall burden of central nervous system cancers.View evidenceHide evidence
Why this verdict
The profile states that absolute risks increased with increasing radon concentration across evaluated metrics and that the authors concluded residential radon may contribute meaningfully to malignant CNS cancer burden. The latter is also supported by the PAF analysis, though interpretation of burden depends on assumptions behind deriving PAFs from observational hazard models.
Study evidence
Cohort experience and outcome count: 159,391 postmenopausal women with mean 17.7 years follow-up; 451 incident malignant CNS cancers identified.
“We estimated the radon-related hazard of incident malignant CNS cancer in a large US cohort of postmenopausal women from the Women's Health Initiative.”
Study evidence
Population attributable fraction for malignant CNS cancer associated with residential radon (Li et al. estimates): 20.1% (95% CI: 4.8%–33.9%) for highest versus lowest tertile.20.1% (4.8%–33.9%)
“Corresponding population attributable fractions were calculated.”
Context layer
What the story left out
Important study details the story did not include.
Quantitative association estimates included a highest-versus-lowest Li et al. tertile HR of 1.49 with 95% CI 1.12–1.99 and spline evidence for increasing hazard.
The story reports the direction of association but does not provide the main hazard ratio, confidence interval, or spline-test detail that would help readers assess effect size and statistical uncertainty.
From Prospective cohort (Women's Health Initiative)
The paper included a secondary population-attributable-fraction analysis, with an example PAF of 20.1% and 95% CI 4.8%–33.9% for one Li et al. radon metric comparison.
The presentation alludes to a possible meaningful contribution to overall CNS cancer burden but does not report the PAF analysis or its numerical estimate and uncertainty.
From secondary data impact estimation (PAF) from cohort hazard models
Interpretation-changing limitations include potential residual confounding and the fact that PAF or burden interpretations require causal assumptions from observational data.
The story hedges the association and mentions indirect exposure estimation, but it does not explicitly discuss residual confounding or the causal assumptions required to interpret attributable-burden estimates.
From Prospective cohort (Women's Health Initiative); secondary data impact estimation (PAF) from cohort hazard models
4 things the story did carry across
- The paper's central evidence is an observational prospective cohort analysis estimating association, not a randomized or causal intervention study.
- The study population was specifically 159,391 U.S. postmenopausal women in the Women's Health Initiative, not the general population.
- Incident malignant brain/CNS cancer outcome count and follow-up: 451 cases over a mean 17.7 years.
- Residential radon exposure was estimated at addresses using multiple external radon metrics/models, including USGS/EPA and LBL/Li estimates, rather than directly measured for each participant.
Study layer
Study at a glance
Scan the study first. Expand only the parts you want to inspect.
Pieces of work
2
Evidence read
study summary
Lead result
human in vivo
1Lead resulthuman in vivoEstimate the association between residential radon concentration and incident malignant brain/CNS cancer risk among US postmenopausal women in the Women’s Health Initiative (WHI), including concentration–response modeling and covariate adjustment.Prospective cohort (Women's Health Initiative)ExpandCollapse
In plain English
Prospective cohort analysis in 159,391 postmenopausal Women’s Health Initiative participants (mean follow-up 17.7 years) relating residential radon concentration (multiple metrics/models) to incident malignant central nervous system (CNS) cancer using adjusted Cox proportional hazards models with continuous (including nonlinear splines) and categorical exposure analyses; higher residential radon was associated with increased malignant CNS cancer hazard and a sizable estimated population attributable fraction.
Key findings
- Cohort experience and outcome count: 159,391 postmenopausal women with mean 17.7 years follow-up; 451 incident malignant CNS cancers identified.
- Continuous exposure–response: nonlinear spline models (USGS, LBL, Li et al.) showed increasing CNS cancer hazard with increasing radon, with a global spline test p = 0.022 for the Li et al. estimates indicating an increase in hazard even at low radon concentrations.Nonlinear increase; Li et al. spline global test p = 0.022
“We estimated the radon-related hazard of incident malignant CNS cancer in a large US cohort of postmenopausal women from the Women's Health Initiative.”
What this piece can’t prove
1 further detail could not be confirmed from the summary.
2secondary dataQuantify potential public-health impact of residential radon exposure on malignant CNS cancer burden via population attributable fractions (PAFs) based on the WHI estimates.secondary data impact estimation (PAF) from cohort hazard modelsExpandCollapse
In plain English
The study computed population attributable fractions (PAFs) for malignant central nervous system (CNS) cancer based on hazard ratios estimated in the Women's Health Initiative cohort to quantify the potential public-health impact of residential radon exposure. An example PAF reported in the abstract was 20.1% (95% CI: 4.8%–33.9%) for the comparison of the highest versus lowest Li et al. radon-estimate tertile.
Key findings
- Population attributable fraction for malignant CNS cancer associated with residential radon (Li et al. estimates): 20.1% (95% CI: 4.8%–33.9%) for highest versus lowest tertile.20.1% (4.8%–33.9%)
“Corresponding population attributable fractions were calculated.”
What this piece can’t prove
- PAFs are based on observational associations from Cox models; causal interpretation requires untestable assumptions about confounding and the counterfactual exposure distribution.
- Abstract does not provide details on the exact PAF calculation formula, reference exposure level, or sensitivity analyses for PAF assumptions (likely in main text/supplement).
- The reported PAF example uses a tertile comparison for one radon metric (Li et al.); PAFs may differ by radon metric or exposure categorization.
Method layer
NewsLink found the paper. Tessa takes you deeper.
NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.
Open the paper in Tessa
Residential Radon Concentration and the Risk of Malignant Brain and Central Nervous System Cancer in US Postmenopausal Women
Neuroepidemiology · 2026
Why this one
Near certain
NewsLink found the paper. Tessa is where you inspect it deeply.
Papers considered
The selected paper, plus nearby candidates.
PubMed, Europe PMC, Crossref · 38 candidate papers
Residential Radon Concentration and the Risk of Malignant Brain and Central Nervous System Cancer in US Postmenopausal Women
Neuroepidemiology · 2026 · PubMed, Europe PMC, Crossref
Residential Radon and Brain Tumour Incidence in a Danish Cohort
PLoS ONE · 2013 · Crossref
Underutilization of Adjuvant Radiation in Malignant Meningioma: Socioeconomic Variation in a Population-Based Cohort
Neuroepidemiology · 2026 · Crossref
Erratum
Neuroepidemiology · 2026 · Crossref
Obituary: Michel Dumas (1934–2025) – A Founding Figure of Tropical Neuroepidemiology
Neuroepidemiology · 2026 · Crossref
Farming History, Insecticide Exposure, and the Risk of ALS Mortality
Neuroepidemiology · 2026 · Crossref
And 32 more candidates considered.